Paper2394831
Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.
Goldberg IJ and 6 others. J Clin Invest, 1990. Cited by 45 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism. Papers, record 2394831. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2394831
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholesterol | Major topic |
| Hypercholesterolemia | Major topic |
| Lovastatin | Major topic |
| Adult | |
| Aged | |
| Colestipol | |
| Female | |
| Humans | |
| Male | |
| Metabolic Clearance Rate | |
| Middle Aged | |
| Niacin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL-21006 | NHLBI NIH HHS | United States | P50HL021006 | PubMed and NIH |
Source NIH RePORTER
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4684130 | A weighted least-squares technique for the analysis of kinetic data and its application to the study of renal xenon washout in dogs and man. | Circ Res | 1973 | https://conductscience.org/library/papers/4684130 | PubMed |
| 2 | 2562787 | Identification of a zinc finger protein that binds to the sterol regulatory element. | Science | 1989 | https://conductscience.org/library/papers/2562787 | PubMed |
| 3 | 4729058 | The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man. | J Clin Invest | 1973 | https://conductscience.org/library/papers/4729058 | PubMed |
| 4 | 1245596 | Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans. | J Clin Invest | 1976 | https://conductscience.org/library/papers/1245596 | PubMed |
| 5 | 518733 | The relation of antemortem characteristics to cardiovascular findings at necropsy--The Framingham Study. | Atherosclerosis | 1979 | https://conductscience.org/library/papers/518733 | PubMed |
| 6 | 7419983 | Prediction of the parameters of whole body cholesterol metabolism in humans. | J Lipid Res | 1980 | https://conductscience.org/library/papers/7419983 | PubMed |
| 7 | 6933445 | Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6933445 | PubMed |
| 8 | 6575399 | Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6575399 | PubMed |
| 9 | 6668452 | Cholesterol turnover and metabolism in two patients with abetalipoproteinemia. | J Lipid Res | 1983 | https://conductscience.org/library/papers/6668452 | PubMed |
| 10 | 6371816 | Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6371816 | PubMed |
| 11 | 6565710 | Plasma mevalonate as a measure of cholesterol synthesis in man. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6565710 | PubMed |
| 12 | 3989391 | Whole body and tissue cholesterol turnover in the baboon. | J Lipid Res | 1985 | https://conductscience.org/library/papers/3989391 | PubMed |
| 13 | 3860301 | 5' end of HMG CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription. | Cell | 1985 | https://conductscience.org/library/papers/3860301 | PubMed |
| 14 | 4067430 | Relationship of the parameters of body cholesterol metabolism with plasma levels of HDL cholesterol and the major HDL apoproteins. | J Lipid Res | 1985 | https://conductscience.org/library/papers/4067430 | PubMed |
| 15 | 3853581 | Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia. | J Lipid Res | 1985 | https://conductscience.org/library/papers/3853581 | PubMed |
| 16 | 3513311 | A receptor-mediated pathway for cholesterol homeostasis. | Science | 1986 | https://conductscience.org/library/papers/3513311 | PubMed |
| 17 | 2610723 | Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers. | Atherosclerosis | 1989 | https://conductscience.org/library/papers/2610723 | PubMed |
| 18 | 2351867 | Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. | J Lipid Res | 1990 | https://conductscience.org/library/papers/2351867 | PubMed |
| 19 | 3746132 | Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotype. | J Lipid Res | 1986 | https://conductscience.org/library/papers/3746132 | PubMed |
| 20 | 3464957 | Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3464957 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40372435 | Allosteric regulation of UBIAD1 trafficking from ER to Golgi revealed by chemical genetic screening. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40372435 | PubMed |
| 38927094 | Paradoxes: Cholesterol and Hypoxia in Preeclampsia. | Biomolecules | 2024 | https://conductscience.org/library/papers/38927094 | PubMed |
| 38319967 | Direct binding to sterols accelerates endoplasmic reticulum-associated degradation of HMG CoA reductase. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38319967 | PubMed |
| 35879350 | Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain. | Nat Commun | 2022 | https://conductscience.org/library/papers/35879350 | PubMed |
| 34842525 | Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1. | Elife | 2021 | https://conductscience.org/library/papers/34842525 | PubMed |
| 32188638 | Schnyder corneal dystrophy-associated UBIAD1 is defective in MK-4 synthesis and resists autophagy-mediated degradation. | J Lipid Res | 2020 | https://conductscience.org/library/papers/32188638 | PubMed |
| 30785396 | Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice. | Elife | 2019 | https://conductscience.org/library/papers/30785396 | PubMed |
| 29107682 | Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase. | Semin Cell Dev Biol | 2018 | https://conductscience.org/library/papers/29107682 | PubMed |
| 28982667 | Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28982667 | PubMed |
| 28694924 | Statins redux: A re-assessment of how statins lower plasma cholesterol. | World J Diabetes | 2017 | https://conductscience.org/library/papers/28694924 | PubMed |
| 27313057 | Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice. | J Lipid Res | 2016 | https://conductscience.org/library/papers/27313057 | PubMed |
| 21369428 | Microbial production and biomedical applications of lovastatin. | Indian J Pharm Sci | 2008 | https://conductscience.org/library/papers/21369428 | PubMed |
| 9118584 | Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/9118584 | PubMed |
| 8349825 | Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8349825 | PubMed |
| 8199696 | Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. | J Gastroenterol | 1994 | https://conductscience.org/library/papers/8199696 | PubMed |
| 1904356 | Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1904356 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HMGCR | 3156 | PubTator's text mining | https://conductscience.org/library/genes/3156 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2394831
GET https://conductscience.org/api/papers/v1/2394831/references?page=2